104 related articles for article (PubMed ID: 3394816)
1. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
Nichols WW; Mehta JL; Thompson L; Donnelly WH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
[TBL] [Abstract][Full Text] [Related]
2. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4.
Wargovich T; Mehta J; Nichols WW; Pepine CJ; Conti CR
J Am Coll Cardiol; 1985 Nov; 6(5):1047-51. PubMed ID: 4045029
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
Nichols WW; Nicolini FA; Yang B; Robbins WC; Katopodis J; Chen L; Saldeen TG; Mehta JL
J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs.
Ito BR; Roth DM; Engler RL
Circ Res; 1990 Mar; 66(3):596-607. PubMed ID: 2137727
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of eicosanoid-mediated coronary constriction during myocardial ischemia.
Laurindo FR; Finton CK; Ezra D; Czaja JF; Feuerstein GZ; Goldstein RE
FASEB J; 1988 Jun; 2(9):2479-86. PubMed ID: 3371592
[TBL] [Abstract][Full Text] [Related]
8. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
Bache RJ; Dai XZ
Cardiovasc Res; 1992 Apr; 26(4):351-6. PubMed ID: 1638566
[TBL] [Abstract][Full Text] [Related]
9. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
Grover GJ; Schumacher WA; Simon M; Parham C
J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
[TBL] [Abstract][Full Text] [Related]
10. [The effect of leukotriene LTC4 on the coronary vascular bed and on myocardial contractile function].
Moĭbenko AA; Kolchin IuN; Bulakh VN; Sorochinskiĭ AE
Biull Eksp Biol Med; 1991 Feb; 111(2):120-3. PubMed ID: 1854947
[TBL] [Abstract][Full Text] [Related]
11. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators.
Stahl GL; Lefer AM
Blood Vessels; 1987; 24(1-2):24-30. PubMed ID: 3567363
[TBL] [Abstract][Full Text] [Related]
13. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
[TBL] [Abstract][Full Text] [Related]
14. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
Kopia GA; Valocik RE; Torphy TJ; Cieslinksi LB; Sarau HM; Foley JJ; Wasserman MA
J Pharmacol Exp Ther; 1987 Apr; 241(1):174-80. PubMed ID: 2437287
[TBL] [Abstract][Full Text] [Related]
18. Effects of leukotriene D4 on large and small coronary arteries in the conscious dog.
Hintze TH; Stern H; Kaley G
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():287-98. PubMed ID: 2949554
[No Abstract] [Full Text] [Related]
19. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.
Sellke FW; Wang SY; Friedman M; Harada K; Edelman ER; Grossman W; Simons M
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1303-11. PubMed ID: 7943375
[TBL] [Abstract][Full Text] [Related]
20. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
